CRIP1 and neoplasm: By studying the The Cancer Genome Atlas (TCGA) GC cohort, we found that the HR deficiency score [14] was significantly decreased in tumor samples with high CRIP1 expression (Fig. 3A), supporting the role of CRIP1 in maintaining HR function in GC cells.